Biocompatibility Innovation
Groundbreaking Technology for
Medical Device Manufacturers
Long lasting, durable medical devices mean fewer invasive procedures for patients.
Biocompatibility Innovation (BCI) develops biostealth technology engineered to transform the medical device industry.
One of the leading challenges in the field today is low biocompatibility, a major cause of device failure and patient complications. Our breakthrough solutions are designed to significantly enhance biocompatibility, resulting in medical devices that are longer-lasting, more durable, and more accessible — all while maintaining full device functionality.
By prioritizing improved patient care and quality of life, BCI aims to set new industry standards for device longevity and durability.
Biostealth Technology
Our patented technology utilizes plant-based active molecules that permanently bond with the materials used in the manufacturing of medical devices.
BCI’s rapidly scalable and regulatory-friendly technology works by inhibiting the leading causes of medical device failure and limited duration.
Biostealth technology counteracts the body’s adverse reactions to prosthetic materials, preventing post-implant degenerative processes that adversely affect the durability and the proper functionality of medical prostheses.
One platform, numerous technologies, unlimited applications
Our Solutions
Almost any prosthetic material – polymers, metals, ceramics, and biologic tissues – used in the manufacturing of medical devices can be protected by our technology.
Barrier against failure
BCI technology solutions are designed to improve patient quality of life by enhancing clinical management and reducing the need for invasive procedures and other complications.
Partnerships
